Abstract:One of the hallmarks of the LH induced granulosa-luteal transition is a conversion from a proliferative, estrogen producing granulosa cell to a differentiated, progestin secreting luteal cell. The B Cell Translocation Gene (BTG) family has been reported to be involved in cell differentiation, antiproliferation, and gene transcription regulation. We hypothesized that BTGs are involved in this process, however, very little is known about them in the ovary. The present study investigated the spatiotemporal expression pattern, regulation and potential function of BTG1, BTG2, and BTG3 in the rat ovary during the periovulatory period. Immature 22-23 days old rats were injected with eCG (10 IU) s.c. to stimulate follicular development and 48h later with hCG (5 IU) s.c. to induce ovulation and subsequent formation of corpora lutea (CL). Animals were killed at different time points after hCG administration (n=3/time point). Ovaries were collected for isolation of total RNA or protein, or processed for in situ hybridization. Granulosa cells were also collected in vivo at different time points for isolation of total RNA or protein. Quantitative real-time PCR analysis revealed that mRNA for Btg1, Btg2, and Btg3 was highly induced both in intact ovaries and granulosa cells by 4 to 8h after hCG stimulation. The expression of Btg1 mRNA in whole ovary was highest between 4 and 8h before decreasing to control levels by 12 and 24h after hCG. The levels of Btg1 mRNA exhibited a similar expression pattern in the granulosa cells (in vivo) to that observed in the whole ovary with the highest expression at 8h. Btg2 mRNA expression in whole ovaries increased 6.5 fold at 4 and 8h after hCG but did not decrease to control levels by 24h, whereas its expression in the granulosa cells (in vivo) continued to increase until 24h after hCG treatment. Btg3 mRNA levels increased 3 fold at 8h after hCG and remained elevated throughout the periovulatory period in both granulosa cells (in vivo) and the whole ovary. In situ hybridization showed that Btg1 mRNA expression was induced in the theca and granulosa cells of some follicles at 4h after hCG injection. Strikingly, there was a switch in the expression from the theca to the granulosa cell compartment at 8 and 12h after hCG. After ovulation, Btg1 mRNA expression was similar to the 0h ovary with little detectable signal in the forming CL. In contrast, Btg2 mRNA expression level was high in luteal cells at 24h after hCG administration. Btg3 mRNA was induced at 8h in granulosa cells after hCG treatment. Regulation of Btg expression was then examined using cultured granulosa cells. Inhibition of progesterone action and the EGF pathway did not change Btg1 and Btg2 mRNA expression, whereas inhibition of prostaglandin synthesis or RUNX activity diminished Btg2 mRNA levels. To determine the function of the BTGs, overexpression of BTG1 or BTG2 resulted in an increase in the percentage of granulosa cells in the G0/G1 phase, whereas the percentage of cells in the S phase decreased. The apoptosis rate in the granulosa cells overexpressing BTG1 or BTG2 also decreased compared to cells infected with the control GFP vector. In conclusion, the induction of BTG1, BTG2, and BTG3 expression after hCG administration and the ability to arrest the cell cycle may be related to theca and granulosa cells differentiation or the establishment of quiescence. (Supported by NIH RR15592 and AG17164)

Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle

Molecular cloning and characterization of a novel human BTB domain-containing gene, , which is down-regulated in glioma

The B Cell Translocation Gene (BTG) Family in the Rat Ovary: Hormonal Induction, Regulation, and Impact on Cell Cycle Kinetics.

Identification and Characterization of Mouse GTPBP3 Gene Encoding a Mitochondrial GTP-binding Protein Involved in Trna Modification

CLONE AND ANALYSIS OF THE HOMOLOGOUS SEQUENCES OF HUMAN TESTIS DEVELOPMENT RELATED GENE 1 IN DIFFERENT SPECIES

Btg1 Inhibits Breast Cancer Cell Growth Through Induction Of Cell Cycle Arrest And Apoptosis

Cloning the Novel BTBD_(10) Gene and Cluster Analysis of Gene Expression in Normal Tissue and Glioma

B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.

BTG/TOB Antiproliferative Protein Family and Tumors

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis

Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1

TBC1D3, a Hominoid Oncoprotein, is Encoded by a Cluster of Paralogues Located on Chromosome 17Q12

Btg1 Expression Correlates With The Pathogenesis And Progression Of Ovarian Carcinomas

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1.

Function of a novel human gene TOX promoting cell proliferation

Cloning,Characterization and Primary Function Study of a Novel Gene,Cymg1,Related to Family 2 Cystatins

Molecular Cloning and Characterization of A Novel Human Btbd8 Gene Containing Double Btb/Poz Domains

P2-04-02: Identification of a Novel Glycosyltransferase-Like Gene As an Autophagic Inducer in Human Mammary Carcinoma Cells Via Down Regulation of BCL-2.

Cloning, tissue expression pattern, and chromosome localization of human protein kinase Bγ gene

Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.